• 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置时时彩网络平台>技术资料首页>行业动态>行业动态>药品开发业务外包(CRO)之全球市场

    赌博不贪心每天赢三百: 药品开发业务外包(CRO)之全球市场

    Global Industry Analysts, Inc.2009年5月19日 16:22 点击:3739

    药品开发业务外包(CRO)之全球市场 Contract Research Outsourcing
    Abstract

    时时彩网络平台 www.qlgr.net This report analyzes the worldwide markets for Contract Research Outsourcing in Millions of US$. The major Service segments analyzed are Drug Discovery, and Clinical Research. The report provides separate comprehensive analytics for the US, Europe, Asia, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 219 companies including many key and niche players worldwide such as Criterium, Inc., Covance, Inc., Encorium Group, Inc., ICON PLC, Covalent Group, Inc., Kendle, Life Sciences Research, Inc., MDS Pharma Services, MPI Research, Omnicare Clinical Research, Parexel International Corporation, PharmaNet Development Group, Inc., PRA International, Pharmaceutical Product Development, Inc., Quintiles Transnational Corporation, WIL Research Laboratories, LLC, Bio Analytical Research Corporation, Calvert Laboratories, Inc., CentraLabS Clinical Research, Charles River Laboratories, Inc., Huntingdon Life Sciences Research, Inc., Lab Research, Inc., Pacific Biometrics, Inc., Perry Scientific, Inc., Quest Diagnostics, Inc., SNBL USA, Ltd., DaVita Clinical Research, nTouch Research Corporation, PharmaTrials, Inc., Radiant Research, Inc., and Research Solutions, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

    Table of Contents

    I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
    • Product Definitions and Scope of Study

    II. EXECUTIVE SUMMARY

    1. Industry Overview

    • Background
    • Growth and Transformation of CRO Industry
    • Table 1: Number of Clinical Trials Worldwide (2000-2007) (includes corresponding Graph/Chart)
    • Table 2: Percentage Breakup of Number of Pipeline Drugs Worldwide by Phase- Preclinical, Phase I, Phase II, Phase III and Phase IV (2007) (includes corresponding Graph/Chart)
    • Advantages of CRO for Pharmaceutical Companies
    • Advantages of CRO for Clinical Research Organizations

    2. Industry Potential

    • Outlook
    • Competition Potential
    • Table 3: Percentage Breakup of Life Sciences Revenues (FY 2007) of Major Players by Service Type- Preclinical, Phase I, Phase IIA, Phase IIB, Phase III, Phase IIIb/IV, Central Lab, Bioanalytical and Others
    • Table 4: Global CRO Market (2007): Number of CROs by Service Type- Phase I, Phase I-IV, Data Management Services (DMS), Regulatory Affairs, Quality Analysis (QA), Preclinical /Toxicology and Lab Analysis (includes corresponding Graph/Chart)
    • Table 5: Global Pre-clinical CRO Market (2007): Percentage Breakup of Market Share Based on Revenues for Charles River Labs, Covance, Life Science Research, MPI Research, SNBL USA, WIL Research Labs, MDS, LAB Research and Others (includes corresponding Graph/Chart)
    • Table 6: Leading Biotechnology and Pharmaceutical Research Companies Worldwide - Ranked by Year 2006 Revenues in US$ Million (includes corresponding Graph/Chart)
    • Regional Potential
    • The United States
    • Western Europe
    • Central and Eastern Europe
    • Asia-Pacific
    • China
    • India
    • Latin America
    • Service Potential
    • Pre-Clinical Segment Gains Momentum
    • Clinical Research - Encouraging Factors at Various Phases
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Research & Development Potential
    • Table 7: Percentage Breakup of Global R&D Spending by Region (2008E) (includes corresponding Graph/Chart)
    • Table 8: Percentage Breakup of Global R&D Spending by Market (2005-2010) (includes corresponding Graph/Chart)
    • Role of Technology in R&D

    3. Market Dynamics

    • Challenges Faced by Contract Research Organizations
    • On-shore versus Offshore CRO Business
    • Cutthroat Competition Among CROs
    • Management of Production Capacities
    • Management of Clinical Investigation
    • Cost Containment
    • Safety Concerns on Clinical Trials
    • Pipeline Blocks
    • Strategies and Tactical Programs for CROs
    • Survival Strategies in Mature CRO Markets
    • Exit from the Industry
    • Expand Scale
    • Capture Niche Segments
    • Expand Geographically
    • Strategies to Tap Opportunities in Growing Markets
    • Mobilize Funds
    • Expand Other Services
    • Upgrade Technological and Knowledge Base
    • Form Sub-Contracts or Regional Alliances
    • Asia - Hub for Contract Research Outsourcing
    • Overview
    • Market Potential
    • Activity Perspective
    • Cost-Efficiency in Research and Development
    • World-Class Clinical Trials
    • Regional Perspective
    • China
    • Congenial Business Environment
    • Compliance with Global CRO Standards
    • Return of Skilled Human Resources
    • Availability of Large Genetic Population
    • Cost Advantages
    • India
    • Large Talent Pool of Human Resources
    • Increased Regulatory Compliance
    • Rich Genetic Diversity
    • Cost-Savings and World-Class Quality
    • Table 9: Cost of Conducting Clinical Trials: India Vs US (In US$ Million) (includes corresponding Graph/Chart)
    • Challenges in Outsourcing
    • China
    • Regulatory Hurdles
    • Limited Funding Resources
    • Demand War for Talented Personnel
    • Teething problems
    • Cultural and Language Difficulties
    • India
    • Restrictions on Clinical Trials
    • Lack of Standardization
    • Advantage India - hot spot for R&D investment
    • Subject-compliance in major therapeutic areas
    • Reliable Data Generation and Management
    • Improved Base of Medical Infrastructure
    • Strong Combination of CMOs and CROs
    • Reverse-engineering Capabilities
    • Market Trends
    • Biotech Leads in CRO

    4. Recent Industry Activity

    • Symyx Takes Over Integrity Biosolution
    • Worldwide Clinical Trials Acquires MediQuest
    • BioImagene Launches a New CRO, AgilityBio
    • Tigermed Receives Investments from Qiming
    • Covance Inks MoU with WuXi for a Chinese Joint Venture
    • Veeda Takes Over International Oncology Network
    • Kendle Acquires DecisionLine
    • Encorium to Take Over Prologue Research
    • PharmaLinkFHI Takes Over Matrix Contract Research Ltd.
    • Encorium Receives Business Contracts for North America and Europe
    • India' s Jubilant Organosys to Takeover Draxis Health
    • Shasun to Establish Process Development Unit in US
    • Quintiles to Open Second Clinical Research Office in Wilmington
    • LabCorp to Acquire Tandem Labs
    • Shasun to Establish Process Development Unit in US
    • MDS Pharma Expands in Latin America
    • Iris Pharma and Clirophtha Merge to Form New Iris Pharma
    • PPD to Acquire InnoPharm
    • KCR Acquires DUX Consuling
    • Cetero Research Acquires DGD Research
    • Jubilant Organosys Acquires Hollister- Stier Laboratories
    • Shasun Acquires Rhodia Pharma Plants
    • Ocimum Biosolutions Acquires Gene Logic' s Genomics Business
    • Innovative Medical Device Sourcing Acquires Frontier BioMedical LLC
    • UK-Based Premier Research Group PLC Acquires ARS, Inc.
    • AAIPharma, Inc. Acquires Instituto de Pesquisa Clinica de Sao Paulo Ltda
    • Covance to Renovate New Drug Development Facility in Virginia
    • Covance Expands and Reshuffles Research Clinic
    • Perceptive Informatics Alliance To Enhance Clinical Supply Chain Forecasting and Management
    • Genstar Capital Acquires PRA International
    • Covalent Acquires Remedium Oy and Changes Name to Encorium
    • Quintiles Enters Into a New Alliance with Washington County Hospital
    • Kendle Expands in US and Europe
    • Criterium Opens Two New Offices in Russia and Israel
    • Premier Research Acquires Two Companies to Expand Product Offerings
    • Averion Divests Staffing Services Segment
    • Chiltern Acquires CTMS
    • Quintiles Acquires Bio-Trials
    • Parexel Acquires Apex International Clinical Research
    • Charles River Forms Joint Venture with BioExplorer
    • PAREXEL Opens New Location In India
    • Avesthagen and Manipal Accunova Collaborate
    • Matrix and ethica Clinical Research Form ethicamatrix
    • Covance Opens Nutritional Chemistry Laboratory in Singapore
    • MDS Pharma to Expand in European Market
    • Vita Nova Acquires Sedoc
    • Averion Acquires Hesperion
    • Averion and BIOCANCER Form Strategic Alliance
    • AstraZeneca Opens First CPU to Enhance Clinical Research in China
    • AstraZeneca Acquires Biologics Manufacturing Facility
    • AstraZeneca Inaugurates Global Process R&D Lab in Bangalore

    5. Focus on Key Players

    • Contract Research Organizations
    • Criterium, Inc. (US)
    • Covance, Inc. (US)
    • Encorium Group, Inc. (US)
    • ICON PLC (Ireland)
    • Kendle (US)
    • Life Sciences Research, Inc. (US)
    • MDS Pharma Services (US)
    • MPI Research (US)
    • Omnicare Clinical Research (US)
    • Parexel International Corporation (US)
    • PharmaNet Development Group, Inc. (US)
    • PRA International (US)
    • Pharmaceutical Product Development, Inc. (US)
    • Quintiles Transnational Corporation (US)
    • WIL Research Laboratories, LLC (US)
    • Preclinical Laboratories
    • Bio Analytical Research Corporation (US)
    • Calvert Laboratories, Inc. (US)
    • CentraLabS Clinical Research (US)
    • Charles River Laboratories, Inc. (US)
    • Huntingdon Life Sciences Research, Inc. (UK)
    • Laboratory Corporation of America(r) Holdings (US)
    • Lab Research, Inc. (Canada)
    • Pacific Biometrics, Inc. (US)
    • Perry Scientific, Inc. (US)
    • Quest Diagnostics, Inc. (US)
    • SNBL USA, Ltd. (US)
    • Site Management Organizations
    • DaVita Clinical Research (US)
    • nTouch Research Corporation (US)
    • PharmaTrials, Inc. (US)
    • Radiant Research, Inc. (US)
    • Research Solutions, LLC (US)

    6. Global Market Perspective

    • Table 10: World Recent Past, Current and Future Analysis for Contract Research Outsourcing by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
    • Table 11: World Long-Term Projections for Contract Research Outsourcing by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
    • Table 12: World 10-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current and Future Analysis for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
    • Table 14: World Long-Term Projections for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
    • Table 15: World 10-Year Perspective for Contract Research Outsourcing for Drug Discovery by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current and Future Analysis for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
    • Table 17: World Long-Term Projections for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
    • Table 18: World 10-Year Perspective for Contract Research Outsourcing for Clinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia-Pacific and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart)

    III. MARKET

    1. The United States

    • A. Market Analysis
      • Largest Market Worldwide
      • Competitive Scenario
      • Table 19: US CRO Market (2007): Percentage Breakdown of CRO Revenues by Player Category (includes corresponding Graph/Chart)
      • Recent Industry Activity
      • Focus on Key Players
      • Contract Research Organizations
      • Preclinical Laboratories
      • Site Management Operations
    • B. Market Analytics
      • Table 20: US Recent Past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000- 2010 (includes corresponding Graph/Chart)
      • Table 21: US Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
      • Table 22: US 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012

    2. Europe

    • A. Market Analysis
      • Significant Market in Contract Research Outsourcing
      • Market Overview
      • Competitive Scenario
      • Eastern Europe - Center for Clinical Trials
      • Recent Industry Activity
      • Select Players
      • ClinTec International Ltd. - A British CRO
      • ICON PLC - An Irish CRO
      • Huntingdon Life Sciences Research, Inc.- A UK-based Preclinical Laboratory
    • B. Market Analytics
      • Table 23: European Recent Past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
      • Table 24: European Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
      • Table 25: European 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012

    3. Asia

    • A. Market Analysis
      • Promising Market
      • Table 26: CRO Market Size (US$ million) for Clinical Research in Asia (2004 - 08) (includes corresponding Graph/Chart)
      • Outsourcing Destinations: China and India
      • Promoting Role of the Government
      • Focus on Key Markets
      • India
      • A Thriving Clinical Trial Market
      • Table 27: Indian CRO Market Revenues in US$ Million (2003-2010) (includes corresponding Graph/Chart)
      • Reasons for Outsourcing to India
      • Table 28: Cost of Conducting Clinical Trials: India Vs US (In US$ Million) (includes corresponding Graph/Chart)
      • List of Pharmaceutical Companies Outsourcing Clinical Research to India
      • SWOT Analysis III-
      • Competitive Scenario
      • Regulatory Environment
      • Major Contract Research Organizations
      • Ace Biomed Pvt. Ltd.
      • Asian Clinical Trials Limited
      • Catalyst Clinical Services Pvt. Ltd.
      • Clinigene International Limited
      • ClinInvent Research Pvt. Ltd.
      • Clintrac International Pvt. Ltd.
      • Clinsys Clinical Research, Inc.
      • Lotus Labs Pvt. Ltd.
      • Nicholas Piramal India Limited.
      • Shasun Chemicals & Drugs Limited
      • SIRO Clinpharm Pvt. Ltd.
      • Vimta Labs
      • China
      • Factors Favoring Outsourcing to China
      • SWOT Analysis
      • Policies Governing Clinical Trials in China
      • Clinical Research Market Size
      • Table 29: CRO Market Size (US$ million) for Clinical Research in China (2004 - 08) (includes corresponding Graph/Chart)
      • Select Contract Research Organizations
      • Astrom Research International
      • Atuka Ltd.
      • Excel PharmaStudies Inc.
      • Gleneagles Clinical Research Center (Singapore)
      • Japan
      • Table 30: Japanese CRO Market (2007): Percentage Breakdown of Value Sales by Segment- Clinical, Devices, Food & Supplement, SMO/CRC, Pre-Clinical and Others (includes corresponding Graph/Chart)
      • Recent Industry Activity
    • B. Market Analytics
      • Table 31: Asian Recent Past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
      • Table 32: Asian Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
      • Table 33: Asian 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012

    4. Rest of World

    • A. Market Analysis
      • Recent Industry Activity
    • B. Market Analytics
      • Table 34: Rest of World Recent Past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart)
      • Table 35: Rest of World Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart)
      • Table 36: Rest of World 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012

    COMPETITIVE LANDSCAPE

    (来源: Global Industry Analysts, Inc. )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, 时时彩网络平台,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 棋牌平台开发价格 白小姐82期透码 二肖中特提前公开验证 百人牛牛牌面分析 海南游玩攻略 京东彩票全天24在线计划 pc北京网站开奖查询 天天十三水有修改器吗 彩票开奖七乐彩走势图 女子网球年终总决赛 双色球复式7+2中4红1蓝多少钱? 真人真钱游戏ea 海南体彩41开奖查询 北京快3基本走势图一定牛 捷克彩铅